Prevalencia de hiperplasia prostática benigna en pacientes de 40 a 60 años atendidos en el Hospital Naval del Sur, período 2020–2025.

Abstract

Introduction: Benign prostatic hyperplasia (BPH) is one of the most common urological conditions in adult men. It is associated with lower urinary tract symptoms, impaired quality of life, and potential obstructive complications. Its frequency increases progressively with age. Materials and Methods: An observational, cross-sectional, retrospective, descriptive and an analytical study was conducted. The study population consisted of 3,350 men aged 40 to 60 years who were treated at Hospital Naval del Sur between 2020 and 2025. Variables such as BPH diagnosis, year of treatment, age group, sociodemographic characteristics, type of treatment received, and urological complications were analyzed. Data were processed using descriptive statistics and the chi-square test to compare prevalence according to age group. Results: A total of 593 patients were identified with a diagnosis of BPH, corresponding to an overall prevalence of 17.7%. The year with the highest prevalence was 2021 (21%). The 50-60 age group accounted for 85.5% (p < 0.001). The majority of patients (84.7%) came from urban areas, mainly from Guayaquil (56.3%). The most common medical treatment was medication used in 68% of all cases. Urological complications occurred in 17.9% of patients, with acute urinary retention being the most frequent. Conclusions: BPH showed a significant prevalence in men aged 40-60, with a predominance in older patients. These findings highlight the importance of timely diagnosis, clinical follow-up, and proper recording of this condition.